Vinicius De Lima Vazquez

Barretos, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

A baseline systemic inflammatory signature predicts anti-PD-1 response in advanced melanoma.

A baseline systemic inflammatory signature predicts anti-PD-1 response in advanced melanoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 19, 2026

Correction: Economic Evaluation of Inguinal Versus Ilio-inguinal Lymphadenectomy for Patients with Stage III Metastatic Melanoma to Groin Lymph Nodes: Evidence from the EAGLE FM Randomized Trial.

Correction: Economic Evaluation of Inguinal Versus Ilio-inguinal Lymphadenectomy for Patients with Stage III Metastatic Melanoma to Groin Lymph Nodes: Evidence from the EAGLE FM Randomized Trial.

Journal: Annals of surgical oncology
Published: April 16, 2025

Exploring blood cell biomarkers in melanoma patients receiving adjuvant anti-PD-1 immunotherapy.

Exploring blood cell biomarkers in melanoma patients receiving adjuvant anti-PD-1 immunotherapy.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 17, 2025

CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival.

CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: October 30, 2024

Economic Evaluation of Inguinal Versus Ilio-inguinal Lymphadenectomy for Patients with Stage III Metastatic Melanoma to Groin Lymph Nodes: Evidence from the EAGLE FM Randomized Trial.

Economic Evaluation of Inguinal Versus Ilio-inguinal Lymphadenectomy for Patients with Stage III Metastatic Melanoma to Groin Lymph Nodes: Evidence from the EAGLE FM Randomized Trial.

Journal: Annals of surgical oncology
Published: October 08, 2024

Evaluation of the antineoplastic properties of the photosensitizer biscyanine in 2D and 3D tumor cell models and artificial skin models.

Evaluation of the antineoplastic properties of the photosensitizer biscyanine in 2D and 3D tumor cell models and artificial skin models.

Journal: Journal of photochemistry and photobiology. B, Biology
Published: September 05, 2024

Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line.

Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line.

Journal: Human cell
Published: December 16, 2023

Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure.

Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure.

Journal: Nature communications
Published: October 16, 2021

Demographic, Clinical, and Pathologic Features of Patients With Cutaneous Melanoma: Final Analysis of the Brazilian Melanoma Group Database.

Demographic, Clinical, and Pathologic Features of Patients With Cutaneous Melanoma: Final Analysis of the Brazilian Melanoma Group Database.

Journal: JCO global oncology
Published: April 16, 2020

Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.

Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.

Journal: Pharmacological research
Published: April 26, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026